Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients

Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients

Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog Veklury (remdesivir) for the treatment of non-hospitalized patients at high risk for Covid-19 disease progression. The Covid-19 drug has been indicated for adults and adolescents. Veklury has been the antiviral standard of care for the treatment of […]

Biocon gets license for Adagio Therapeutics’ ADG20 for Covid-19 treatment

Biocon gets license for Adagio Therapeutics’ ADG20 for Covid-19 treatment

Biocon Limited said that its subsidiary Biocon Biologics has been given an exclusive license from Adagio Therapeutics, a US-based biotech company, for manufacturing and commercializing an antibody treatment based on ADG20 for India and certain emerging markets. ADG20 is a novel monoclonal antibody that targets the spike protein of SARS-CoV-2 and related coronaviruses. It is […]

Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy

Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy

Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of 77.8% against symptomatic Covid-19 in phase 3 clinical trials. Efficacy analysis of the Bharat Biotech vaccine showed that it was 93.4% effective against severe symptomatic Covid-19. Against asymptomatic Covid-19, the […]

Seegene gets $4.8m order for supplying Covid-19 diagnostic kits to Kuwait

Seegene gets $4.8m order for supplying Covid-19 diagnostic kits to Kuwait

Seegene, a South Korean molecular diagnostics company has been given an order worth more than $4.8 million for supplying its Allplex SARS-CoV-2 Assay Covid-19 diagnostic kits. The exclusive supply agreement was signed by Seegene MIDDLE EAST, the company’s local subsidiary, with the Ministry of Health (MOH) of Kuwait. As per the terms of the agreement, […]

DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG

DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG

The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research and Development Organisation (DRDO) for the treatment of Covid-19. The DRDO drug has been approved as an adjunct therapy in Covid-19 patients having moderate to severe infection. As it is a generic molecule and analogue of glucose, […]

CORAT begins COR-101 clinical trial in hospitalized Covid patients

CORAT begins COR-101 clinical trial in hospitalized Covid patients

CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101 for the treatment of hospitalized Covid-19 patients. According to the German pharma company, COR-101 can complement presently approved antibody drugs, which are not indicated for patients with moderate to severe Covid-19 because of side effects during advanced […]

Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005

Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005

Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials from the National Center for Advancing Translational Sciences (NCATS) at the US National Institutes of Health (NIH). SPI-1005 is an oral capsule, which contains a small molecule called ebselen that […]

Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective

Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective

Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized with Covid-19 has failed to meet its primary endpoints. ITAC expands to Inpatient Treatment with Anti-Coronavirus Immunoglobulin. Also called INSIGHT-013, the late-stage trial was sponsored and supported by the US National Institute of Allergy […]

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. The Janssen vaccine is the fourth Covid-19 vaccine authorized in the European Union (EU) after the vaccines developed by BioNTech and Pfizer, Moderna, and AstraZeneca. Ursula von der […]

Pfizer begins phase 1 study of Covid drug candidate PF-07321332

Pfizer begins phase 1 study of Covid drug candidate PF-07321332

Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that causes Covid-19. The US pharma giant said that it has completed the dosing of single ascending doses in the participating healthy adults in the early-stage clinical trial. Pfizer will now […]